Serva Energy’s sample measurement of the rare, cancer-killing medical isotope Actinium-225 has been validated by the Massachusetts Institute of Technology (MIT) Nuclear Research Laboratory.
It’s the latest milestone in Serva’s development of commercial quantities of Actinium-225 (Ac-225) needed for next-generation Targeted Alpha Therapies.Continue reading
A new study led by researchers at Barrow Neurological Institute has found that people living in regions with median levels of air pollution have a 56 percent greater risk of developing Parkinson’s disease compared to those living in regions with the lowest level of air pollution.Continue reading
Forbion leads Series A, with participation from founding seed investor OrbiMed and additional new investors RA Capital Management and HealthCap
As part of the President’s Investing in America agenda, the U.S. Department of Commerce leverages Tech Hubs Program to spur regional innovation and job creation.Continue reading
Arizona State University President Michael M. Crow, joined by Phoenix Mayor Kate Gallego, today announced that the university’s headquarters for ASU Health, which includes a new medical school, will be built at a location to be determined in downtown Phoenix.Continue reading
SCOTTSDALE, Ariz. — Oct. 18, 2023 — In a significant breakthrough that could eventually extend the survival of patients with one of the deadliest of all malignancies, an international team of researchers have devised an investigational blood test that might one day help doctors detect pancreatic cancer earlier.Continue reading
ROOT, Switzerland–Oct 12, 2023 (BUSINESS WIRE)– Novocure (NASDAQ: NVCR) today announced it has entered into an agreement with Stanford University to establish the Stanford School of Medicine Tumor Treating Fields (TTFields) Research Program. The program is intended to support both preclinical studies and clinical trials with TTFields, electric fields that exert physical forces to kill cancer cells via a variety of mechanisms.Continue reading
TUCSON, Ariz. – NeuTherapeutics, a Tucson startup founded to commercialize University of Arizona technology has received a $2.5M Small Business Innovation Research (SBIR) grant from the National Institutes of Health/ National Institute on Aging (NIA) to conduct a Phase 2 clinical trial to evaluate the impact of a new dietary supplement, PhytoSERM, on menopausal hot flashes in women.Continue reading